Human leukocyte antigen (HLA)-I plays a critical role in presenting processed antigens to T cells, facilitated by β2-microglobulin (β2m) to enhance the stability and peptide loading of MHC molecules on the cell surface.β2m mutations have been identified as a significant cause of HLA-I loss in tumor cells [45]. This evidence concerns the gene HLA-C and neoplasm.